HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MPV17
mitochondrial inner membrane protein MPV17
Chromosome 2 Β· 2p23.3
NCBI Gene: 4358Ensembl: ENSG00000115204.16HGNC: HGNC:7224UniProt: A0A0S2Z3Z9
57PubMed Papers
22Diseases
0Drugs
91Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
peroxisomechannel activitymitochondrionmitochondrial inner membranemitochondrial DNA depletion syndrome 6 (hepatocerebral type)Charcot-Marie-Tooth disease, axonal, type 2EEmitochondrial DNA depletion syndromemitochondrial DNA depletion syndrome 15 (hepatocerebral type)
✦AI Summary

MPV17 is a mitochondrial inner membrane protein that functions as a non-selective ion channel modulating mitochondrial membrane potential and maintaining mitochondrial homeostasis 1. The channel has a pore diameter of 1.8 nm with weak cation selectivity and voltage-dependent gating regulated by redox conditions and pH 1. Beyond channel function, MPV17 is critically involved in mitochondrial DNA (mtDNA) maintenance through regulation of mitochondrial deoxynucleoside triphosphate (dNTP) pool homeostasis, with evidence suggesting a role in pyrimidine de novo synthesis pathway 2. Loss of MPV17 function causes elevated mitochondrial membrane potential, increased reactive oxygen species production, and accelerated mitochondrial fission 1. Pathogenic MPV17 variants cause mitochondrial DNA depletion syndrome type 6 and Charcot-Marie-Tooth disease axonal type 2EE 3. MPV17 mutations are associated with hepatocerebral forms of mtDNA depletion syndromes, typically presenting with early-onset liver dysfunction and neurological involvement 4. In pediatric acute liver failure of indeterminate origin, MPV17 defects represent the second most frequent genetic finding after NBAS 5. Preliminary therapeutic approaches using pyrimidine supplementation show promise in restoring mtDNA content in MPV17-deficient models 2.

Sources cited
1
MPV17 forms a non-selective ion channel with 1.8 nm pore diameter that modulates mitochondrial membrane potential and homeostasis, with voltage-dependent gating regulated by redox and pH conditions
PMID: 25861990
2
MPV17 is one of 20 nuclear genes linked to mitochondrial DNA maintenance defects, functioning in maintaining balanced mitochondrial nucleotide pools
PMID: 28215579
3
MPV17 is essential for mitochondrial structure and functionality, with a role in pyrimidine synthesis; pyrimidine supplementation restores iridophore number and mtDNA content in MPV17-deficient zebrafish
PMID: 30833296
4
MPV17 mutations cause hepatocerebral mitochondrial DNA depletion syndrome presenting with early-onset liver dysfunction and neurological involvement
PMID: 23385875
5
MPV17 defects are the second most frequent genetic finding in pediatric acute liver failure of indeterminate origin, identified in 8 of 260 cases with 37% overall diagnostic yield
PMID: 37976411
6
MPV17 mutations in maintenance genes are associated with leukoencephalopathy in primary mitochondrial diseases
PMID: 39322395
Disease Associationsβ“˜22
mitochondrial DNA depletion syndrome 6 (hepatocerebral type)Open Targets
0.85Strong
Charcot-Marie-Tooth disease, axonal, type 2EEOpen Targets
0.75Strong
mitochondrial DNA depletion syndromeOpen Targets
0.70Moderate
mitochondrial DNA depletion syndrome 15 (hepatocerebral type)Open Targets
0.48Moderate
mitochondrial diseaseOpen Targets
0.45Moderate
liver failureOpen Targets
0.37Weak
cholestasisOpen Targets
0.37Weak
Hepatic failureOpen Targets
0.37Weak
mitochondrial DNA depletion syndrome, hepatocerebral formOpen Targets
0.32Weak
genetic disorderOpen Targets
0.19Weak
Pain insensitivityOpen Targets
0.18Weak
diabetes mellitusOpen Targets
0.07Suggestive
cancerOpen Targets
0.05Suggestive
Beta-thalassemia - X-linked thrombocytopeniaOpen Targets
0.05Suggestive
beta-thalassemia-X-linked thrombocytopenia syndromeOpen Targets
0.05Suggestive
hemoglobin D diseaseOpen Targets
0.05Suggestive
dominant beta-thalassemiaOpen Targets
0.04Suggestive
Hemoglobin E - beta-thalassemiaOpen Targets
0.04Suggestive
hemoglobin E-beta-thalassemia syndromeOpen Targets
0.04Suggestive
ThrombocytopeniaOpen Targets
0.04Suggestive
Charcot-Marie-Tooth disease, axonal, type 2EEUniProt
Mitochondrial DNA depletion syndrome 6UniProt
Pathogenic Variants91
NM_002437.5(MPV17):c.70+1G>APathogenic
not provided|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2026
NM_002437.5(MPV17):c.461+2T>CPathogenic
not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|MPV17-related disorder|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE
β˜…β˜…β˜†β˜†2026
NM_002437.5(MPV17):c.280-1dupPathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2026
NM_002437.5(MPV17):c.428T>G (p.Leu143Ter)Pathogenic
not provided|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 143
NM_002437.5(MPV17):c.376-1G>APathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025
NM_002437.5(MPV17):c.376-2A>CPathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|Charcot-Marie-Tooth disease, axonal, type 2EE|not provided|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025
NM_002437.5(MPV17):c.179del (p.Gly60fs)Pathogenic
not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 60
NM_002437.5(MPV17):c.459C>G (p.Tyr153Ter)Likely pathogenic
Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 153
NM_002437.5(MPV17):c.375+2T>CLikely pathogenic
not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025
NM_002437.5(MPV17):c.149G>A (p.Arg50Gln)Pathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|not provided|Mitochondrial DNA depletion syndrome|Charcot-Marie-Tooth disease, axonal, type 2EE|MPV17-related disorder|Mitochondrial disease|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 50
NM_002437.5(MPV17):c.191C>G (p.Pro64Arg)Pathogenic
not provided|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)|Mitochondrial DNA depletion syndrome|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 64
NM_002437.5(MPV17):c.148C>T (p.Arg50Trp)Pathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form|Mitochondrial DNA depletion syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 50
NM_002437.5(MPV17):c.186+2T>CPathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE|Uterine corpus endometrial carcinoma
β˜…β˜…β˜†β˜†2025
NM_002437.5(MPV17):c.71-1G>TLikely pathogenic
not provided|Charcot-Marie-Tooth disease, axonal, type 2EE
β˜…β˜…β˜†β˜†2025
NM_002437.5(MPV17):c.451dup (p.Leu151fs)Pathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 151
NM_002437.5(MPV17):c.206G>A (p.Trp69Ter)Pathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|MPV17-related mitochondrial DNA maintenance defect|not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 69
NM_002437.5(MPV17):c.122G>A (p.Arg41Gln)Pathogenic
Charcot-Marie-Tooth disease, axonal, type 2EE|not provided|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)|MPV17-related disorder|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 41
NM_002437.5(MPV17):c.293C>T (p.Pro98Leu)Pathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|not provided|MPV17-related disorder|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome 6 (hepatocerebral type);Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome|Mitochondrial DNA maintenance disorder|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 98
NM_002437.5(MPV17):c.370C>T (p.Gln124Ter)Pathogenic
not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 124
NM_002437.5(MPV17):c.260AGA[1] (p.Lys88del)Pathogenic
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)|not provided|Charcot-Marie-Tooth disease, axonal, type 2EE|Mitochondrial DNA depletion syndrome, hepatocerebral form
β˜…β˜…β˜†β˜†2025β†’ Residue 88
View on ClinVar β†—
Related Genes
POLGProtein interaction94%MPV17L2Protein interaction92%MPV17LProtein interaction91%ATXN8Protein interaction90%IMMTProtein interaction85%AGLProtein interaction84%
Tissue Expression6 tissues
Heart
100%
Ovary
81%
Lung
72%
Brain
64%
Liver
60%
Bone Marrow
55%
Gene Interaction Network
Click a node to explore
MPV17POLGMPV17L2MPV17LATXN8IMMTAGL
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt P39210
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.37LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.00 [0.75–1.37]
RankingsWhere MPV17 stands among ~20K protein-coding genes
  • #7,984of 20,598
    Most Researched57
  • #840of 5,498
    Most Pathogenic Variants91 Β· top quartile
  • #14,264of 17,882
    Most Constrained (LOEUF)1.37
Genes detectedMPV17
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Mitochondrial DNA maintenance defects.
PMID: 28215579
Biochim Biophys Acta Mol Basis Dis Β· 2017
1.00
2
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
0.90
3
Genetic landscape of pediatric acute liver failure of indeterminate origin.
PMID: 37976411
Hepatology Β· 2024
0.80
4
Primary mitochondrial diseases.
PMID: 39322395
Handb Clin Neurol Β· 2024
0.70
5
Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.
PMID: 23385875
Neurotherapeutics Β· 2013
0.60